Skip to main content

Unique Cash-flow Issues Facing Health Care Companies

Journal Issue
Column Name
Journal HTML Content

<p>Paramount in dealing with health care companies is an appreciation for the technical expertise needed to
understand the potential pitfalls and uncertainties of the billing and collection cycle. Health care companies
suffer from an often unpredictable and largely misunderstood cash-flow cycle—both of which are the result
of the complicated governmental payment methodologies. (It almost makes preparing tax returns look
simple). But it's not all bad news, believe it or not; the government agencies overpay as well as underpay
providers. Holding onto the government's money can be great for the troubled company's cash flow—until
they ask for it back.

</p><h3>Health Care Receivables</h3>

<p>Accounts receivable in the health care industry are primarily generated by three classes of payors: (a)
Medicare, (b) Medicaid and (c) other payors, primarily consisting of private insurance, managed care and
self-pay. As payors, these entities agree to accept financial responsibility for payment of medical costs
incurred by a patient.

</p><p>Medicare was first established to provide health insurance for the nation's elderly and was later
expanded to include coverage for disabled individuals and individuals suffering from certain terminal
diseases. Medicare is administered through two parts—Part A and Part B. Part A provides coverage for
hospitalization and other inpatient services, such as care at a skilled nursing facility; Part B covers
outpatient services, such as traditional physician care and physical therapy. The U.S. Department of Health
and Human Services (HHS) operates and manages Medicare through the Health Care Financing
Administration (HCFA). A network of non-governmental "fiscal intermediaries" and Part B carriers are
contracted by HCFA to process claims, audit cost reports, detect overpayments and issue payments to
entities that provide health care-related services to patients. These health care providers include, but are not
limited to, physicians, hospitals, nursing facilities, therapists, laboratories, radiological groups and medical
equipment suppliers. The fiscal intermediaries and Part B carriers are insurance companies such as Blue
Cross/Blue Shield or Mutual of Omaha.

</p><p>Medicaid is a joint federal and state program established to provide basic medical care for the nation's
indigent. Broad federal guidelines issued by HCFA generally govern Medicaid; however, specific program
parameters are controlled on the state level and vary from state to state, further complicating the billing and
collections cycle. Additionally, individual states are responsible for administering all aspects of the
program, including provider reimbursement.

</p><p>Most facility-based providers derive the majority of their revenue from government payors, with other
payors such as private insurance, HMOs and PPOs, Veterans Administration and self-pay comprising the
balance.

</p><blockquote><blockquote>
<hr>
<big><i><center>
The administrative burden of the varied and complex billing and collection requirements and voluminous
patient data, combined with unstable operations, could dramatically impact the cash flow of a health care
company in financial distress.
</center></i></big>
<hr>
</blockquote></blockquote>

<h3>Cash-flow Issues</h3>

<p><i>Medicare.</i> Services covered by Medicare are usually subject to the establishment of medical necessity.
Failure by the providers to establish and document medical necessity for services rendered can result in
denied claims, an extended billing and collections process or, in certain circumstances, allegations of fraud.

</p><p>Medicare determines provider reimbursement by using two general payment
methodologies—retrospective and prospective determination. Under retrospective reimbursement, providers
are reimbursed for services rendered to Medicare beneficiaries via interim payments (based on the
provider's historical cost structure) with a periodic adjustment based on the provider's actual costs, subject
to certain limitations. Generally, this adjustment is triggered by the filing of a cost report—a detailed report
of actual revenue and expenses recorded by the provider and subsequently used by the fiscal intermediary
to determine the provider's final reimbursement. The settlement usually involves a cost report audit by the
fiscal intermediary, and finalization of the provider's reimbursement generally takes several years.

</p><p>Under prospective reimbursement, providers are paid based on a pre-determined "fee schedule" that is
adjusted periodically based on inflation and other factors. Medicare is in the process of eliminating most
retrospective reimbursement programs, due in part to the disincentives for providers to reduce costs,
thereby increasing its overall Medicare reimbursement. Prospective reimbursement methodologies eliminate
these trend disincentives and allow providers to benefit from cost improvements.

</p><p>Regardless of the reimbursement methodology, Medicare calculates provider payments on either
estimated service volumes, which are referred to as provider interim payments (PIP), or actual service levels
determined by periodic claim submissions. The PIP payment method routinely results in providers being
under- or over-paid due to changes in the providers' service volume. Periodic PIP adjustments are made
by the fiscal intermediary to reflect current service volumes.

</p><p>Therefore, the process for determining final provider reimbursement (retrospective or prospective), the
manner in which providers are paid on an interim basis (PIP estimates or actual claims) and the lengthy
settlement process all contribute to volatile cash flow cycles.

</p><p><i>Medicaid.</i> Medicaid pays most providers under prospective payment systems. However, some states
reimburse providers on a retrospective basis for certain types of services—usually inpatient. Under
Medicaid, retrospectively reimbursed providers face the same reimbursement and cost-report exposure
issues arising under Medicare retrospective reimbursement programs, thus contributing to cash-flow
uncertainties.

</p><p><i>Private Insurance/Managed Care.</i> With private insurance and managed care, payors generally require
pre-certification for non-primary care services and often require concurrent review for inpatient and other
intense outpatient services. Managed-care companies impose extensive administrative billing requirements
and often delay payments by requesting additional supporting documentation. Providers often deal with
many different managed-care plans and insurance companies, each having unique billing and collection
methodologies. Managed-care payors are often the slowest payors and the most expensive to bill and
collect.

</p><p>Disputes between providers and managed-care payors over appropriate rates and fee schedules occur
often and are difficult to resolve. Material disputes over fee schedules, discounts and covered benefits can
adversely affect cash flows, and may ultimately result in revenue recognition issues.

</p><p><i>Cost Report Contingencies.</i> Providers also face the uncertainty of having prior period cost reports
audited by their fiscal intermediaries, potentially resulting in additional repayments due to disallowed costs
and disagreements over other filing positions taken by providers. For financial statement purposes,
providers routinely establish reserves for potential disallowances as a result of cost-report audits, and
account for these reserves as a contra-asset netted in the receivable accounts. Although required by the
Generally Accepted Accounting Principles (GAAP), these "controversial" reserves were the foundation of
the Department of Justice's case against the Columbia/HCA executives recently convicted of Medicare
fraud.

</p><p><i>Classification Contingencies.</i> Providers are also subject to disputes with Medicare and Medicaid over
the classification and intensity of services where reimbursement differentials exist for closely related service
levels. An example of this dispute is with Medicare over the classification of a patient's illness into
pre-defined categories called Diagnosis Related Groups (DRG), the billing methodology used by Medicare
to calculate reimbursement amounts to hospitals. A hospital's clinical documentation of a patient's
condition and services provided results in classification into one of many possible DRG categories (<i>i.e.,</i>

viral pneumonia would have a significantly different reimbursement level than bacterial pneumonia).
Problems arise when the provider is unable to document to Medicare's satisfaction that the patient's
condition was consistent with the DRG category chosen by the hospital. In situations where the hospital
has insufficient documentation to support the DRG category, the hospital must repay the difference
between, for example, a $5,000 DRG vs. a $6,000 DRG. Still worse, widespread or systematic instances
of unsubstantiated DRG categories often result in allegations of Medicare fraud and abuse. This illustrates
the importance of staff training and accurate medical records to ensure correct billing.

</p><p><i>Contractual Allowance or Bad Debt?</i> Contractual allowances and bad debt expenses are often
misunderstood. Contractual allowances are used to reduce the provider's gross revenue to the level the
provider expects to actually receive from the payor. For example, a surgeon may perform a surgical
procedure for which she charges $10,000 and expects Medicare to cover $6,000. In this example, the
surgeon would record a contractual allowance of $4,000. If Medicare later determines, by clinical review,
that the surgical procedure was less complicated than originally claimed and reimburses only $5,500, the
recorded contractual allowance of $4,000 is then understated and must be adjusted by the $500 difference.
In this scenario, the failure to collect the fully recorded revenue represents an underestimation of the
contractual allowance, not bad debt. However, if a managed-care payor unilaterally imposes a fee schedule
adjustment to the same procedure (in spite of a valid provider agreement), the potentially uncollectible
difference most likely represents a bad debt. The general guideline is that if a provider was never entitled to
the recorded revenue, the uncollected amount represents a contractual allowance. If the provider is
contractually entitled to the revenue, but does not collect for any reason, the uncollected amount is considered
a bad debt.

</p><p>The administrative burden of the varied and complex billing and collection requirements and
voluminous patient data, combined with unstable operations, could dramatically impact the cash flow of
a health care company in financial distress.

</p><h3>Bankruptcy Complications</h3>

<p><i>Recoupment and Set-offs.</i> Retrospective reimbursement systems and estimated PIP volumes impose risk
and financial exposure to both the provider and the Medicare program itself. In the event that a provider's
interim rate was set too high, that provider faces the prospect of repaying potentially large sums of money
to the Medicare program. Similarly, if estimated PIP service volumes are higher than the provider's actual
service levels, the provider faces either lump-sum repayments or recoupment. Conversely, poor
management of receivables can lead to large Medicare or Medicaid underpayments, causing cash shortage
issues.

</p><p>When a health care provider files for protection under chapter 11, Medicare and/or Medicaid may
attempt to assert a post-petition right to set-off (<i>i.e.,</i> recoupment) in order to satisfy certain pre-petition
overpayments or other obligations. If material overpayments have occurred, recoupment actions could
potentially devastate the debtor's cash flow and thwart its best efforts to reorganize.

</p><p>The legal bases used by Medicare and Medicaid to assert their right of set-off, as well as the debtor's
defense thereto, are complex and cannot be comprehensively covered in this article. However, the general
approaches taken by governmental payors to avoid the automatic stay can be summarized as follows: (a)
mutual debts arising from the same transaction, (b) implied assumption of the provider agreement or (c)
sovereign immunity. In response, debtors usually argue that (a) the "same transaction" analysis is not valid
because periodic true-ups represent new transactions, (b) the debtors have not assumed the provider
agreement and (c) the court has an overwhelming public interest in preventing recoupment as it seriously
jeopardizes the debtor's ability to reorganize and to continue to provide critical health care services.

</p><p>The bankruptcy courts are responsible for balancing the public interest factor and the debtors' ability
to reorganize with the rights of the government payors. However, in recent Delaware cases, the courts have
ruled in favor of the debtors and have not permitted the government to recoup in order to satisfy pre-petition
obligations.

</p><p>In a bankruptcy scenario, managed-care payors may attempt to move toward even slower payment
cycles. These payors may attempt to set-off and/or recoup against pre-petition obligations such as
incurred-but-not-reported claims, or an estimate of claims liabilities that have been incurred by a covered
member but not reported to payors through the claims process.

</p><p>In bankruptcy situations, health care companies have had some success in maintaining effective control
of receipt flow by communicating effectively with government regulators and payors. If the government
regulators believe that the provider is in control of the receivables process and is cognizant of the
government's interests, as well as its patient care services, the government may be less likely to
aggressively assert set-offs and recoupments after the provider files for protection.

</p><h3>Conclusion</h3>

<p>The risk factors related to a health care company's cash-flow cycle can jeopardize its management's
ability to fund operations and meet debt service. Therefore, it is imperative that health care companies are
able to quickly determine the precise reason for any changes in the billing and collections cycle. Simply
recognizing that cash flow from receivables has declined is insufficient. Management's reactions must be
swift in order to remedy any interruption in the cycle.

</p><hr>

Journal Date